Insight into the current Toxoplasma gondii DNA vaccine: a review article

References

• Halonen SK, Weiss LM. Toxoplasmosis. Handb Clin Neurol. 2013;114:125–145. .
   PubMedGoogle Scholar
• Chowdhury MN. Toxoplasmosis: a review. J Med. 1986;17(5–6):373–396.
   PubMedGoogle Scholar
• Saadatnia G, Golkar M. A review on human toxoplasmosis. Scand J Infect Dis. 2012;44(11):805–814.
   PubMed Web of Science ®Google Scholar
• Boughattas S, Bergaoui R, Essid R, et al. Seroprevalence of Toxoplasma gondii infection among horses in Tunisia. Parasit Vectors. 2011 Nov 22;4(1):218.
   PubMedGoogle Scholar
• Wang M, Wang YH, Ye Q, et al. Serological survey of Toxoplasma gondii in Tibetan mastiffs (Canis lupus familiaris) and yaks (Bos grunniens) in Qinghai, China. Parasit Vectors. 2012 Feb 13;5(1):35.
   PubMedGoogle Scholar
• Yang N, Mu MY, Li HK, et al. Seroprevalence of Toxoplasma gondii infection in slaughtered chickens, ducks, and geese in Shenyang, northeastern China. Parasit Vectors. 2012 Oct 18;5(1):237.
   PubMedGoogle Scholar
• Mevelec MN, Bout D, Desolme B, et al. Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice. Vaccine. 2005 Aug 22;23(36):4489–4499.
   PubMed Web of Science ®Google Scholar
• Dubey JP. The history of Toxoplasma gondii–the first 100 years. J Eukaryot Microbiol. 2008 Nov-Dec;55(6):467–475.
   PubMed Web of Science ®Google Scholar
• Ji-Long S, Li Y. Prevalence and fundamental researches of prevention and treatment of toxoplasmosis in China: an overview. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2019 Apr 2;31(1):71–76.
   PubMedGoogle Scholar
• Kur J, Holec-Gasior L, Hiszczyńska-Sawicka E. Current status of toxoplasmosis vaccine development. Expert Rev Vaccines. 2009 Jun;8(6):791–808.
   PubMed Web of Science ®Google Scholar
• Liu Q, Singla LD, Zhou H. Vaccines against Toxoplasma gondii: status, challenges and future directions. Hum Vaccin Immunother. 2012 Sep;8(9):1305–1308.
   PubMed Web of Science ®Google Scholar
• Fox BA, Bzik DJ. De novo pyrimidine biosynthesis is required for virulence of Toxoplasma gondii. Nature. 2002 Feb 21;415(6874):926–929.
   PubMed Web of Science ®Google Scholar
• Ghaffarifar F. Strategies of DNA vaccines against toxoplasmosis. Rev Med Microbiol. 2015;26(3):88–90.
   Google Scholar
• Yang H, Wang FY. Research progress of DNA vaccines. Chin Anim Husbandry Vet Med. 2013;40(1):72–76.
   Google Scholar
• Saade F, Petrovsky N. Technologies for enhanced efficacy of DNA vaccines. Expert Rev Vaccines. 2012 Feb;11(2):189–209.
   PubMed Web of Science ®Google Scholar
• Ahmadpour E, Sarvi S, Hashemi Soteh MB, et al. Enhancing immune responses to a DNA vaccine encoding Toxoplasma gondii GRA14 by calcium phosphate nanoparticles as an adjuvant. Immunol Lett. 2017 May;185:40–47.
   PubMed Web of Science ®Google Scholar
• Hu LY, Zhang NZ, Zhang FK, et al. Resistance to chronic Toxoplasma gondii infection induced by a DNA vaccine expressing GRA16. Biomed Res Int. 2017;2017:1295038.
   PubMed Web of Science ®Google Scholar
• Zhu WN, Wang JL, Chen K, et al. Evaluation of protective immunity induced by DNA vaccination with genes encoding Toxoplasma gondii GRA17 and GRA23 against acute toxoplasmosis in mice. Exp Parasitol. 2017 Aug;179:20–27.
   PubMed Web of Science ®Google Scholar
• Peng GH, Yuan ZG, Zhou DH, et al. Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice. Vaccine. 2009 Nov 5;27(47):6570–6574.
   PubMed Web of Science ®Google Scholar
• Liu MM, Yuan ZG, Peng GH, et al. Toxoplasma gondii microneme protein 8 (MIC8) is a potential vaccine candidate against toxoplasmosis. Parasitol Res. 2010 Apr;106(5):1079–1084
   PubMed Web of Science ®Google Scholar
• Chen J, Zhou DH, Li ZY, et al. Toxoplasma gondii: protective immunity induced by rhoptry protein 9 (TgROP9) against acute toxoplasmosis. Exp Parasitol. 2014 Apr;139:42–48.
   PubMed Web of Science ®Google Scholar
• Wang HL, Wang YJ, Pei YJ, et al. DNA vaccination with a gene encoding Toxoplasma gondii rhoptry protein 17 induces partial protective immunity against lethal challenge in mice. Parasite. 2016;23:4.
   PubMedGoogle Scholar
• Zhang Z, Li Y, Wang M, et al. Immune protection of rhoptry protein 21 (ROP21) of Toxoplasma gondii as a DNA vaccine against toxoplasmosis. Front Microbiol. 2018;9:909.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Li Y, Xie Q, et al. The molecular characterization and immunity identification of rhoptry protein 22 of Toxoplasma gondii as a DNA vaccine candidate against toxoplasmosis. J Eukaryot Microbiol. 2019 Jan;66(1):147–157
   PubMed Web of Science ®Google Scholar
• Zhang Z, Li Y, Liang Y, et al. Molecular characterization and protective immunity of rhoptry protein 35 (ROP35) of Toxoplasma gondii as a DNA vaccine. Vet Parasitol. 2018 Aug 30;260:12–21. DOI:10.1016/j.vetpar.2018.06.016.
   PubMed Web of Science ®Google Scholar
• Yang WB, Zhou DH, Zou Y, et al. Vaccination with a DNA vaccine encoding Toxoplasma gondii ROP54 induces protective immunity against toxoplasmosis in mice. Acta Trop. 2017 Dec;176:427–432.
   PubMed Web of Science ®Google Scholar
• Lu G, Zhou A, Meng M, et al. Alpha-galactosylceramide enhances protective immunity induced by DNA vaccine of the SAG5D gene of Toxoplasma gondii. BMC Infect Dis. 2014 Dec 20;14(1):3862.
   PubMedGoogle Scholar
• Li J, Huang X, Zhang G, et al. Immune response and protective efficacy against homologous challenge in BALB/c mice vaccinated with DNA vaccine encoding Toxoplasma gondii actin depolymerizing factor gene. Vet Parasitol. 2011 Jun 30;179(1–3):1–6.
   PubMed Web of Science ®Google Scholar
• Zhao G, Zhou A, Lu G, et al. Identification and characterization of Toxoplasma gondii aspartic protease 1 as a novel vaccine candidate against toxoplasmosis. Parasit Vectors. 2013 Jun 14;6(1):175.
   PubMedGoogle Scholar
• Huang SY, Chen K, Wang JL, et al. Evaluation of protective immunity induced by recombinant calcium-dependent protein kinase 1 (TgCDPK1) protein against acute toxoplasmosis in mice. Microb Pathog. 2019 Aug;133:103560.
   PubMed Web of Science ®Google Scholar
• Zhao G, Zhou A, Lv G, et al. Toxoplasma gondii cathepsin proteases are undeveloped prominent vaccine antigens against toxoplasmosis. BMC Infect Dis. 2013 May 7;13(1):207.
   PubMedGoogle Scholar
• Han Y, Zhou A, Lu G, et al. DNA Vaccines encoding toxoplasma gondii cathepsin C 1 induce protection against toxoplasmosis in mice. Korean J Parasitol. 2017 Oct;55(5):505–512
   PubMed Web of Science ®Google Scholar
• Hassan IA, Wang S, Xu L, et al. DNA vaccination with a gene encoding Toxoplasma gondii Deoxyribose Phosphate Aldolase (TgDPA) induces partial protective immunity against lethal challenge in mice. Parasit Vectors. 2014 Sep 8;7(1):431.
   PubMedGoogle Scholar
• Wang S, Wang Y, Sun X, et al. Protective immunity against acute toxoplasmosis in BALB/c mice induced by a DNA vaccine encoding Toxoplasma gondii elongation factor 1-alpha. BMC Infect Dis. 2015 Oct 24;15(1):448.
   PubMedGoogle Scholar
• Chen J, Huang SY, Li ZY, et al. Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice. Vaccine. 2013 Mar 25;31(13):1734–1739.
   PubMed Web of Science ®Google Scholar
• Guo HT, Li ZY, Wang JL, et al. Immune responses induced by pVAX/TgERK7 against Toxoplasma gondii Infection in BALB/c Mice. Iran J Parasitol. 2019 Oct-Dec;14(4):552–562.
   PubMed Web of Science ®Google Scholar
• Hassan IA, Wang S, Xu L, et al. Immunoglobulin and cytokine changes induced following immunization with a DNA vaccine encoding Toxoplasma gondii selenium-dependent glutathione reductase protein. Exp Parasitol. 2014 Nov;146:1–10.
   PubMed Web of Science ®Google Scholar
• Wang S, Hassan IA, Liu X, et al. Immunological changes induced by Toxoplasma gondii Glutathione-S-Transferase (TgGST) delivered as a DNA vaccine. Res Vet Sci. 2015 Apr;99:157–164.
   PubMed Web of Science ®Google Scholar
• Chen J, Huang SY, Zhou DH, et al. DNA immunization with eukaryotic initiation factor-2alpha of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice. Vaccine. 2013 Dec 16;31(52):6225–6231.
   PubMed Web of Science ®Google Scholar
• Cui X, Lei T, Yang D, et al. Toxoplasma gondii immune mapped protein-1 (TgIMP1) is a novel vaccine candidate against toxoplasmosis. Vaccine. 2012 Mar 16;30(13):2282–2287.
   PubMed Web of Science ®Google Scholar
• Hassan IA, Wang S, Xu L, et al. Immunological response and protection of mice immunized with plasmid encoding Toxoplasma gondii glycolytic enzyme malate dehydrogenase. Parasite Immunol. 2014 Dec;36(12):674–683
   PubMed Web of Science ®Google Scholar
• Zheng B, Ding J, Lou D, et al. The virulence-related MYR1 protein of toxoplasma gondii as a novel DNA vaccine against toxoplasmosis in mice. Front Microbiol. 2019;10:734.
   PubMed Web of Science ®Google Scholar
• Yan HK, Yuan ZG, Petersen E, et al. Toxoplasma gondii: protective immunity against experimental toxoplasmosis induced by a DNA vaccine encoding the perforin-like protein 1. Exp Parasitol. 2011 May;128(1):38–43
   PubMed Web of Science ®Google Scholar
• Zhao Y, Li ZY, Chen J, et al. Protective efficacy of pVAX-RON5p against acute and chronic infections of Toxoplasma gondii in BALB/c mice. Exp Parasitol. 2016 Apr;163:24–30.
   PubMed Web of Science ®Google Scholar
• Liu Y, Cao A, Li Y, et al. Immunization with a DNA vaccine encoding Toxoplasma gondii Superoxide dismutase (TgSOD) induces partial immune protection against acute toxoplasmosis in BALB/c mice. BMC Infect Dis. 2017 Jun 7;17(1):403.
   PubMedGoogle Scholar
• Zheng B, Ding J, Chen X, et al. Immuno-efficacy of a T. gondii secreted protein with an altered Thrombospondin Repeat (TgSPATR) as a novel DNA vaccine candidate against acute toxoplasmosis in BALB/c mice. Front Microbiol. 2017;8:216.
   PubMed Web of Science ®Google Scholar
• Zhou J, Wang L, Lu G, et al. Epitope analysis and protection by a ROP19 DNA vaccine against Toxoplasma gondii. Parasite. 2016;23:17.
   PubMedGoogle Scholar
• Lu G, Zhou J, Zhao YH, et al. DNA vaccine ROP29 from Toxoplasma gondii containing R848 enhances protective immunity in mice. Parasite Immunol. 2018 Oct;40(10):e12578
   PubMed Web of Science ®Google Scholar
• Lu G, Wang L, Zhou A, et al. Epitope analysis, expression and protection of SAG5A vaccine against Toxoplasma gondii. Acta Trop. 2015 Jun;146:66–72.
   PubMed Web of Science ®Google Scholar
• Naserifar R, Ghaffarifar F, Dalimi A, et al. Evaluation of immunogenicity of cocktail DNA vaccine containing plasmids encoding complete GRA5, SAG1, and ROP2 antigens of Toxoplasma gondii in BALB/C mice. Iran J Parasitol. 2015 Oct-Dec;10(4):590–598.
   PubMed Web of Science ®Google Scholar
• Cao A, Liu Y, Wang J, et al. Toxoplasma gondii: vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice. Vaccine. 2015 Nov 27;33(48):6757–6762.
   PubMed Web of Science ®Google Scholar
• Khodadadi M, Ghaffarifar F, Dalimi A, et al. Immunogenicity of in-silico designed multi-epitope DNA vaccine encoding SAG1, SAG3 and SAG5 of Toxoplasma gondii adjuvanted with CpG-ODN against acute toxoplasmosis in BALB/c mice. Acta Trop. 2021 Apr;216:105836.
   PubMed Web of Science ®Google Scholar
• Angus CW, Klivington-Evans D, Dubey JP, et al. Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents. J Infect Dis. 2000 Jan;181(1):317–324
   PubMed Web of Science ®Google Scholar
• Dzierszinski F, Mortuaire M, Cesbron-Delauw MF, et al. Targeted disruption of the glycosylphosphatidylinositol-anchored surface antigen SAG3 gene in Toxoplasma gondii decreases host cell adhesion and drastically reduces virulence in mice. Mol Microbiol. 2000 Aug;37(3):574–582
   PubMed Web of Science ®Google Scholar
• Laguia-Becher M, Martin V, Kraemer M, et al. Effect of codon optimization and subcellular targeting on Toxoplasma gondii antigen SAG1 expression in tobacco leaves to use in subcutaneous and oral immunization in mice. BMC Biotechnol. 2010 Jul 15;10(1):52.
   PubMedGoogle Scholar
• Carruthers VB, Sibley LD. Sequential protein secretion from three distinct organelles of Toxoplasma gondii accompanies invasion of human fibroblasts. Eur J Cell Biol. 1997 Jun;73(2):114–123.
   PubMed Web of Science ®Google Scholar
• El Hajj H, Lebrun M, Arold ST, et al. ROP18 is a rhoptry kinase controlling the intracellular proliferation of Toxoplasma gondii. PLoS Pathog. 2007 Feb;3(2):e14
   PubMed Web of Science ®Google Scholar
• Joiner KA, Roos DS. Secretory traffic in the eukaryotic parasite Toxoplasma gondii: less is more. J Cell Biol. 2002 May 13;157(4):557–563.
   PubMed Web of Science ®Google Scholar
• Ngo HM, Hoppe HC, Joiner KA. Differential sorting and post-secretory targeting of proteins in parasitic invasion. Trends Cell Biol. 2000 Feb;10(2):67–72.
   PubMed Web of Science ®Google Scholar
• Foroutan M, Ghaffarifar F, Sharifi Z, et al. Rhoptry antigens as Toxoplasma gondii vaccine target. Clin Exp Vaccine Res. 2019 Jan;8(1):4–26
   PubMed Web of Science ®Google Scholar
• Li ZY, Lu J, Zhang NZ, et al. Immune responses induced by HSP60 DNA vaccine against toxoplasma gondii infection in Kunming mice. Korean J Parasitol. 2018 Jun;56(3):237–245
   PubMed Web of Science ®Google Scholar
• Li ZY, Lu J, Zhang NZ, et al. Immunization with plasmid DNA expressing heat shock protein 40 confers prophylactic protection against chronic Toxoplasma gondii infection in Kunming mice. Parasite. 2018;25:37.
   PubMedGoogle Scholar
• Mohamed RM, Aosai F, Chen M, et al. Induction of protective immunity by DNA vaccination with Toxoplasma gondii HSP70, HSP30 and SAG1 genes. Vaccine. 2003 Jun 20;21(21–22):2852–2861.
   PubMed Web of Science ®Google Scholar
• Chen J, Li ZY, Huang SY, et al. Protective efficacy of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) adjuvated with recombinant IL-15 and IL-21 against experimental toxoplasmosis in mice. BMC Infect Dis. 2014 Sep 6;14(1):487.
   PubMedGoogle Scholar
• Chen K, Wang JL, Huang SY, et al. Immune responses and protection after DNA vaccination against Toxoplasma gondii calcium-dependent protein kinase 2 (TgCDPK2). Parasite. 2017;24:41.
   PubMedGoogle Scholar
• Morlon-Guyot J, Berry L, Chen CT, et al. The Toxoplasma gondii calcium-dependent protein kinase 7 is involved in early steps of parasite division and is crucial for parasite survival. Cell Microbiol. 2014 Jan;16(1):95–114
   PubMed Web of Science ®Google Scholar
• Zhang NZ, Huang SY, Xu Y, et al. Evaluation of immune responses in mice after DNA immunization with putative Toxoplasma gondii calcium-dependent protein kinase 5. Clin Vaccine Immunol. 2014 Jul;21(7):924–929.
   PubMedGoogle Scholar
• Zhang NZ, Huang SY, Zhou DH, et al. Protective immunity against Toxoplasma gondii induced by DNA immunization with the gene encoding a novel vaccine candidate: calcium-dependent protein kinase 3. BMC Infect Dis. 2013 Oct 31;13(1):512.
   PubMedGoogle Scholar
• Zhang NZ, Xu Y, Wang M, et al. Vaccination with Toxoplasma gondii calcium-dependent protein kinase 6 and rhoptry protein 18 encapsulated in poly(lactide-co-glycolide) microspheres induces long-term protective immunity in mice. BMC Infect Dis. 2016 Apr 18;16(1):168.
   PubMedGoogle Scholar
• Mineo JR, McLeod R, Mack D, et al. Antibodies to Toxoplasma gondii major surface protein (SAG-1, P30) inhibit infection of host cells and are produced in murine intestine after peroral infection. J Immunol. 1993;150(9):3951–3964.
   PubMed Web of Science ®Google Scholar
• Mineo JR, Kasper LH. Attachment of Toxoplasma gondii to host cells involves major surface protein, SAG-1 (P30). Exp Parasitol. 1994 Aug;79(1):11–20.
   PubMed Web of Science ®Google Scholar
• Grimwood J, Smith JE. Toxoplasma gondii: the role of parasite surface and secreted proteins in host cell invasion. Int J Parasitol. 1996 Feb;26(2):169–173.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yin H. Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii. Parasit Vectors. 2014 Apr 13;7(1):180.
   PubMedGoogle Scholar
• Cong H, Zhang M, Xin Q, et al. Compound DNA vaccine encoding SAG1/ SAG3 with A2/B subunit of cholera toxin as a genetic adjuvant protects BALB/c mice against Toxoplasma gondii. Parasit Vectors. 2013 Mar 13;6(1):63.
   PubMedGoogle Scholar
• Hoseinian Khosroshahi K, Ghaffarifar F, D’Souza S, et al. Evaluation of the immune response induced by DNA vaccine cocktail expressing complete SAG1 and ROP2 genes against toxoplasmosis. Vaccine. 2011 Jan 17;29(4):778–783.
   PubMed Web of Science ®Google Scholar
• Maraghi S, Ghadiri AA, Tavalla M, et al. Evaluation of immunogenicity and protective effect of DNA vaccine encoding surface antigen1 (SAG1) of Toxoplasma gondii and TLR-5 ligand as a genetic adjuvant against acute toxoplasmosis in BALB/c mice. Biologicals. 2019 Nov;62:39–49.
   PubMed Web of Science ®Google Scholar
• Mavi SA, Modarressi MH, Mohebali M, et al. Assessment of the immunogenicity and protective efficiency of a novel dual-promoter DNA vaccine, harboring SAG1 and GRA7 genes, from RH strain of Toxoplasma gondii in BALB/c mice. Infect Drug Resist. 2019;12:2519–2530.
   PubMed Web of Science ®Google Scholar
• Meng M, He S, Zhao G, et al. Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice. Parasit Vectors. 2012 Nov 26;5(1):273.
   PubMedGoogle Scholar
• Wu XN, Lin J, Lin X, et al. Multicomponent DNA vaccine-encoding Toxoplasma gondii GRA1 and SAG1 primes: anti-Toxoplasma immune response in mice. Parasitol Res. 2012 Nov;111(5):2001–2009.
   PubMed Web of Science ®Google Scholar
• Zhou H, Min J, Zhao Q, et al. Protective immune response against Toxoplasma gondii elicited by a recombinant DNA vaccine with a novel genetic adjuvant. Vaccine. 2012 Feb 27;30(10):1800–1806.
   PubMed Web of Science ®Google Scholar
• Liu Q, Shang L, Jin H, et al. The protective effect of a Toxoplasma gondii SAG1 plasmid DNA vaccine in mice is enhanced with IL-18. Res Vet Sci. 2010 Aug;89(1):93–97
   PubMed Web of Science ®Google Scholar
• Gao Q, Zhang NZ, Zhang FK, et al. Immune response and protective effect against chronic Toxoplasma gondii infection induced by vaccination with a DNA vaccine encoding profilin. BMC Infect Dis. 2018 Mar 7;18(1):117.
   PubMedGoogle Scholar
• Zhang M, Zhao L, Song J, et al. DNA vaccine encoding the Toxoplasma gondii bradyzoite-specific surface antigens SAG2CDX protect BALB/c mice against type II parasite infection. Vaccine. 2013 Sep 23;31(41):4536–4540.
   PubMed Web of Science ®Google Scholar
• Lu G, Zhou J, Zhou A, et al. SAG5B and SAG5C combined vaccine protects mice against Toxoplasma gondii infection. Parasitol Int. 2017 Oct;66(5):596–602
   PubMed Web of Science ®Google Scholar
• Zhou J, Wang L. SAG4 DNA and peptide vaccination provides partial protection against T. gondii infection in BALB/c mice. Front Microbiol. 2017;8:1733.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yin H. Research advances in microneme protein 3 of Toxoplasma gondii. Parasit Vectors. 2015 Jul 22;8(1):384.
   PubMedGoogle Scholar
• Cerede O, Dubremetz JF, Soete M, et al. Synergistic role of micronemal proteins in Toxoplasma gondii virulence. J Exp Med. 2005 Feb 7;201(3):453–463.
   PubMed Web of Science ®Google Scholar
• Reiss M, Viebig N, Brecht S, et al. Identification and characterization of an escorter for two secretory adhesins in Toxoplasma gondii. J Cell Biol. 2001 Feb 5;152(3):563–578.
   PubMed Web of Science ®Google Scholar
• Meissner M, Reiss M, Viebig N, et al. A family of transmembrane microneme proteins of Toxoplasma gondii contain EGF-like domains and function as escorters. J Cell Sci. 2002 Feb 1;115(Pt 3):563–574.
   PubMed Web of Science ®Google Scholar
• Baldi DL, Andrews KT, Waller RF, et al. RAP1 controls rhoptry targeting of RAP2 in the malaria parasite Plasmodium falciparum. Embo J. 2000 Jun 1;19(11):2435–2443.
   PubMed Web of Science ®Google Scholar
• Pinzan CF, Sardinha-Silva A, Almeida F, et al. Vaccination with recombinant microneme proteins confers protection against experimental toxoplasmosis in mice. PLoS One. 2015;10(11):e0143087.
   PubMed Web of Science ®Google Scholar
• Brossier F, David Sibley L. Toxoplasma gondii: microneme protein MIC2. Int J Biochem Cell Biol. 2005 Nov;37(11):2266–2272.
   PubMed Web of Science ®Google Scholar
• Dautu G, Munyaka B, Carmen G, et al. Toxoplasma gondii: DNA vaccination with genes encoding antigens MIC2, M2AP, AMA1 and BAG1 and evaluation of their immunogenic potential. Exp Parasitol. 2007 Jul;116(3):273–282
   PubMed Web of Science ®Google Scholar
• Ismael AB, Hedhli D, Cerede O, et al. Further analysis of protection induced by the MIC3 DNA vaccine against T. gondii: CD4 and CD8 T cells are the major effectors of the MIC3 DNA vaccine-induced protection, both Lectin-like and EGF-like domains of MIC3 conferred protection. Vaccine. 2009 May 14;27(22):2959–2966.
   PubMed Web of Science ®Google Scholar
• Xiang W, Qiong Z, Li-peng L, et al. The location of invasion-related protein MIC3 of Toxoplasma gondii and protective effect of its DNA vaccine in mice. Vet Parasitol. 2009 Dec 3;166(1–2):1–7.
   PubMed Web of Science ®Google Scholar
• Fang R, Feng H, Hu M, et al. Evaluation of immune responses induced by SAG1 and MIC3 vaccine cocktails against Toxoplasma gondii. Vet Parasitol. 2012 Jun 8;187(1–2):140–146.
   PubMed Web of Science ®Google Scholar
• Fang R, Nie H, Wang Z, et al. Protective immune response in BALB/c mice induced by a suicidal DNA vaccine of the MIC3 gene of Toxoplasma gondii. Vet Parasitol. 2009 Oct 14;164(2–4):134–140.
   PubMed Web of Science ®Google Scholar
• Gong P, Cao L, Guo Y, et al. Toxoplasma gondii: protective immunity induced by a DNA vaccine expressing GRA1 and MIC3 against toxoplasmosis in BALB/c mice. Exp Parasitol. 2016 Jul;166:131–136.
   PubMed Web of Science ®Google Scholar
• Qu D, Han J, Du A. Evaluation of protective effect of multiantigenic DNA vaccine encoding MIC3 and ROP18 antigen segments of Toxoplasma gondii in mice. Parasitol Res. 2013 Jul;112(7):2593–2599.
   PubMed Web of Science ®Google Scholar
• Yan HK, Yuan ZG, Song HQ, et al. Vaccination with a DNA vaccine coding for perforin-like protein 1 and MIC6 induces significant protective immunity against Toxoplasma gondii. Clin Vaccine Immunol. 2012 May;19(5):684–689
   PubMedGoogle Scholar
• Zhang NZ, Gao Q, Wang M, et al. Immunization with a DNA vaccine cocktail encoding TgPF, TgROP16, TgROP18, TgMIC6, and TgCDPK3 genes protects mice against chronic toxoplasmosis. Front Immunol. 2018;9:1505.
   PubMed Web of Science ®Google Scholar
• Li ZY, Chen J, Petersen E, et al. Synergy of mIL-21 and mIL-15 in enhancing DNA vaccine efficacy against acute and chronic Toxoplasma gondii infection in mice. Vaccine. 2014 May 23;32(25):3058–3065.
   PubMed Web of Science ®Google Scholar
• Yuan ZG, Ren D, Zhou DH, et al. Evaluation of protective effect of pVAX-TgMIC13 plasmid against acute and chronic Toxoplasma gondii infection in a murine model. Vaccine. 2013 Jun 28;31(31):3135–3139.
   PubMed Web of Science ®Google Scholar
• Tao Q, Fang R, Zhang W, et al. Protective immunity induced by a DNA vaccine-encoding Toxoplasma gondii microneme protein 11 against acute toxoplasmosis in BALB/c mice. Parasitol Res. 2013 Aug;112(8):2871–2877
   PubMed Web of Science ®Google Scholar
• Dlugonska H. Toxoplasma rhoptries: unique secretory organelles and source of promising vaccine proteins for immunoprevention of toxoplasmosis. J Biomed Biotechnol. 2008;2008:632424.
   PubMedGoogle Scholar
• Bradley PJ, Sibley LD. Rhoptries: an arsenal of secreted virulence factors. Curr Opin Microbiol. 2007 Dec;10(6):582–587.
   PubMed Web of Science ®Google Scholar
• Wei F, Wang W, Liu Q. Protein kinases of Toxoplasma gondii: functions and drug targets. Parasitol Res. 2013 Jun;112(6):2121–2129.
   PubMed Web of Science ®Google Scholar
• Quan JH, Chu JQ, Ismail HA, et al. Induction of protective immune responses by a multiantigenic DNA vaccine encoding GRA7 and ROP1 of Toxoplasma gondii. Clin Vaccine Immunol. 2012 May;19(5):666–674
   PubMedGoogle Scholar
• Sonaimuthu P, Ching XT, Fong MY, et al. Induction of Protective Immunity against toxoplasmosis in BALB/c Mice Vaccinated with Toxoplasma gondii Rhoptry-1. Front Microbiol. 2016;7:808.
   PubMed Web of Science ®Google Scholar
• Foroutan M, Barati M, Ghaffarifar F. Enhancing immune responses by a novel multi-epitope ROP8 DNA vaccine plus interleukin-12 plasmid as a genetic adjuvant against acute Toxoplasma gondii infection in BALB/c mice. Microb Pathog. 2020 Oct;147:104435.
   PubMed Web of Science ®Google Scholar
• Foroutan M, Ghaffarifar F, Sharifi Z, et al. Vaccination with a novel multi-epitope ROP8 DNA vaccine against acute Toxoplasma gondii infection induces strong B and T cell responses in mice. Comp Immunol Microbiol Infect Dis. 2020 Apr;69:101413.
   PubMed Web of Science ®Google Scholar
• Vazini H, Ghafarifar F, Sharifi Z, et al. Evaluation of immune responses induced by GRA7 and ROP2 genes by DNA vaccine cocktails against acute toxoplasmosis in BALB/c mice. Avicenna J Med Biotechnol. 2018 Jan-Mar;10(1):2–8.
   PubMedGoogle Scholar
• Wang L, Lu G, Zhou A, et al. Evaluation of immune responses induced by rhoptry protein 5 and rhoptry protein 7 DNA vaccines against Toxoplasma gondii. Parasite Immunol. 2016 Apr;38(4):209–217
   PubMed Web of Science ®Google Scholar
• Zhang J, He S, Jiang H, et al. Evaluation of the immune response induced by multiantigenic DNA vaccine encoding SAG1 and ROP2 of Toxoplasma gondii and the adjuvant properties of murine interleukin-12 plasmid in BALB/c mice. Parasitol Res. 2007 Jul;101(2):331–338
   PubMed Web of Science ®Google Scholar
• Zhu YC, He Y, Liu JF, et al. Adjuvantic cytokine IL-33 improves the protective immunity of cocktailed DNA vaccine of ROP5 and ROP18 against toxoplasma gondii infection in mice. Parasite. 2020;27:26.
   PubMedGoogle Scholar
• Parthasarathy S, Fong MY, Ramaswamy K, et al. Protective immune response in BALB/c mice induced by DNA vaccine of the ROP8 gene of Toxoplasma gondii. Am J Trop Med Hyg. 2013 May;88(5):883–887
   PubMed Web of Science ®Google Scholar
• Chen Y, Yu M, Hemandez JA, et al. Immuno-efficacy of DNA vaccines encoding PLP1 and ROP18 against experimental Toxoplasma gondii infection in mice. Exp Parasitol. 2018 May;188:73–78.
   PubMed Web of Science ®Google Scholar
• Yuan ZG, Zhang XX, Lin RQ, et al. Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18. Vaccine. 2011 Sep 2;29(38):6614–6619.
   PubMed Web of Science ®Google Scholar
• Wang PY, Yuan ZG, Petersen E, et al. Protective efficacy of a Toxoplasma gondii rhoptry protein 13 plasmid DNA vaccine in mice. Clin Vaccine Immunol. 2012 Dec;19(12):1916–1920
   PubMedGoogle Scholar
• Liu Q, Wang F, Wang G, et al. Toxoplasma gondii: immune response and protective efficacy induced by ROP16/GRA7 multicomponent DNA vaccine with a genetic adjuvant B7-2. Hum Vaccin Immunother. 2014;10(1):184–191.
   PubMed Web of Science ®Google Scholar
• Yuan ZG, Zhang XX, He XH, et al. Protective immunity induced by Toxoplasma gondii rhoptry protein 16 against toxoplasmosis in mice. Clin Vaccine Immunol. 2011 Jan;18(1):119–124
   PubMedGoogle Scholar
• Xu Y, Zhang NZ, Tan QD, et al. Evaluation of immuno-efficacy of a novel DNA vaccine encoding Toxoplasma gondii rhoptry protein 38 (TgROP38) against chronic toxoplasmosis in a murine model. BMC Infect Dis. 2014 Sep 30;14(1):525.
   PubMedGoogle Scholar
• Nam HW. GRA proteins of Toxoplasma gondii: maintenance of host-parasite interactions across the parasitophorous vacuolar membrane. Korean J Parasitol. 2009 Oct;47(Suppl):S29–37.
   PubMedGoogle Scholar
• Mercier C, Dubremetz JF, Rauscher B, et al. Biogenesis of nanotubular network in Toxoplasma parasitophorous vacuole induced by parasite proteins. Mol Biol Cell. 2002 Jul;13(7):2397–2409
   PubMed Web of Science ®Google Scholar
• Jongert E, de Craeye S, Dewit J, et al. GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii. Parasite Immunol. 2007 Sep;29(9):445–453
   PubMed Web of Science ®Google Scholar
• Ching XT, Fong MY, Lau YL. Evaluation of the protective effect of deoxyribonucleic acid vaccines encoding granule antigen 2 and 5 against acute toxoplasmosis in BALB/c Mice. Am J Trop Med Hyg. 2017 Jun;96(6):1441–1447.
   PubMed Web of Science ®Google Scholar
• Chu JQ, Huang S, Ye W, et al. Evaluation of protective immune response induced by a DNA vaccine encoding GRA8 against acute toxoplasmosis in a murine model. Korean J Parasitol. 2018 Aug;56(4):325–334
   PubMed Web of Science ®Google Scholar
• Labruyere E, Lingnau M, Mercier C, et al. Differential membrane targeting of the secretory proteins GRA4 and GRA6 within the parasitophorous vacuole formed by Toxoplasma gondii. Mol Biochem Parasitol. 1999 Aug 20;102(2):311–324.
   PubMed Web of Science ®Google Scholar
• Lecordier L, Moleon-Borodowsky I, Dubremetz JF, et al. Characterization of a dense granule antigen of Toxoplasma gondii (GRA6) associated to the network of the parasitophorous vacuole. Mol Biochem Parasitol. 1995 Mar;70(1–2):85–94
   PubMed Web of Science ®Google Scholar
• Sun XM, Zou J, AE A, et al. DNA vaccination with a gene encoding Toxoplasma gondii GRA6 induces partial protection against toxoplasmosis in BALB/c mice. Parasit Vectors. 2011 Nov 9;4(1):213.
   PubMedGoogle Scholar
• Zheng B, Lou D, Ding J, et al. GRA24-based DNA vaccine prolongs survival in mice challenged with a virulent Toxoplasma gondii strain. Front Immunol. 2019;10:418.
   PubMed Web of Science ®Google Scholar
• Xu XP, Liu WG, Xu QM, et al. Evaluation of immune protection against Toxoplasma gondii infection in mice induced by a multi-antigenic DNA vaccine containing TgGRA24, TgGRA25 and TgMIC6. Parasite. 2019;26:58.
   PubMedGoogle Scholar
• Gupta RS, Golding GB. Evolution of HSP70 gene and its implications regarding relationships between archaebacteria, eubacteria, and eukaryotes. J Mol Evol. 1993 Dec;37(6):573–582.
   PubMed Web of Science ®Google Scholar
• Kuppner MC, Gastpar R, Gelwer S, et al. The role of heat shock protein (hsp70) in dendritic cell maturation: hsp70 induces the maturation of immature dendritic cells but reduces DC differentiation from monocyte precursors. Eur J Immunol. 2001 May;31(5):1602–1609
   PubMed Web of Science ®Google Scholar
• Lourido S, Shuman J, Zhang C, et al. Calcium-dependent protein kinase 1 is an essential regulator of exocytosis in Toxoplasma. Nature. 2010 May 20;465(7296):359–362.
   PubMed Web of Science ®Google Scholar
• Lourido S, Tang K, Sibley LD. Distinct signalling pathways control Toxoplasma egress and host-cell invasion. Embo J. 2012 Dec 12;31(24):4524–4534.
   PubMed Web of Science ®Google Scholar
• Uboldi AD, McCoy JM, Blume M, et al. Regulation of starch stores by a Ca(2+)-dependent protein kinase is essential for viable cyst development in Toxoplasma gondii. Cell Host Microbe. 2015 Dec 9;18(6):670–681.
   PubMed Web of Science ®Google Scholar
• Chen J, Li ZY, Petersen E, et al. Co-administration of interleukins 7 and 15 with DNA vaccine improves protective immunity against Toxoplasma gondii. Exp Parasitol. 2016 Mar;162:18–23.
   PubMed Web of Science ®Google Scholar
• Dowse TJ, Pascall JC, Brown KD, et al. Apicomplexan rhomboids have a potential role in microneme protein cleavage during host cell invasion. Int J Parasitol. 2005 Jun;35(7):747–756
   PubMed Web of Science ®Google Scholar
• Brossier F, Jewett TJ, Sibley LD, et al. A spatially localized rhomboid protease cleaves cell surface adhesins essential for invasion by Toxoplasma. Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4146–4151.
   PubMed Web of Science ®Google Scholar
• Zhang NZ, Xu Y, Wang M, et al. Protective efficacy of two novel DNA vaccines expressing Toxoplasma gondii rhomboid 4 and rhomboid 5 proteins against acute and chronic toxoplasmosis in mice. Expert Rev Vaccines. 2015;14(9):1289–1297.
   PubMed Web of Science ®Google Scholar
• Han Y, Zhou A, Lu G, et al. Protection via a ROM4 DNA vaccine and peptide against Toxoplasma gondii in BALB/c mice. BMC Infect Dis. 2017 Jan 11;17(1):59.
   PubMedGoogle Scholar
• Rahimi MT, Sarvi S, Sharif M, et al. Immunological evaluation of a DNA cocktail vaccine with co-delivery of calcium phosphate nanoparticles (CaPNs) against the Toxoplasma gondii RH strain in BALB/c mice. Parasitol Res. 2017 Feb;116(2):609–616
   PubMed Web of Science ®Google Scholar
• Santos JM, Ferguson DJ, Blackman MJ, et al. Intramembrane cleavage of AMA1 triggers Toxoplasma to switch from an invasive to a replicative mode. Science. 2011 Jan 28;331(6016):473–477.
   PubMed Web of Science ®Google Scholar
• Hehl AB, Lekutis C, Grigg ME, et al. Toxoplasma gondii homologue of plasmodium apical membrane antigen 1 is involved in invasion of host cells. Infect Immun. 2000 Dec;68(12):7078–7086
   PubMed Web of Science ®Google Scholar
• Gong P, Huang X, Yu Q, et al. The protective effect of a DNA vaccine encoding the Toxoplasma gondii cyclophilin gene in BALB/c mice. Parasite Immunol. 2013 Mar-Apr;35(3–4):140–146
   PubMed Web of Science ®Google Scholar
• Fischer G, Aumuller T. Regulation of peptide bond cis/trans isomerization by enzyme catalysis and its implication in physiological processes. Rev Physiol Biochem Pharmacol. 2003;148:105–150.
   PubMed Web of Science ®Google Scholar
• Koblansky AA, Jankovic D, Oh H, et al. Recognition of profilin by Toll-like receptor 12 is critical for host resistance to Toxoplasma gondii. Immunity. 2013 Jan 24;38(1):119–130.
   PubMed Web of Science ®Google Scholar
• Plattner F, Yarovinsky F, Romero S, et al. Toxoplasma profilin is essential for host cell invasion and TLR11-dependent induction of an interleukin-12 response. Cell Host Microbe. 2008 Feb 14;3(2):77–87.
   PubMed Web of Science ®Google Scholar
• Zhang NZ, Gao Q, Wang M, et al. Protective efficacy against acute and chronic toxoplasma gondii infection induced by immunization with the DNA vaccine TgDOC2C. Front Microbiol. 2018;9:2965.
   PubMed Web of Science ®Google Scholar
• Song P, He S, Zhou A, et al. Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii. BMC Infect Dis. 2017 Jan 5;17(1):19.
   PubMedGoogle Scholar
• Zheng L, Hu Y, Hua Q, et al. Protective immune response in mice induced by a suicidal DNA vaccine encoding NTPase-II gene of Toxoplasma gondii. Acta Trop. 2017 Feb;166:336–342.
   PubMed Web of Science ®Google Scholar
• Suhrbier A. Multi-epitope DNA vaccines. Immunol Cell Biol. 1997;75(4):402–408.
   PubMed Web of Science ®Google Scholar
• Tong JC, Ren EC. Immunoinformatics: current trends and future directions. Drug Discov Today. 2009 Jul;14(13–14):684–689.
   PubMed Web of Science ®Google Scholar
• Patronov A, Doytchinova I. T-cell epitope vaccine design by immunoinformatics. Open Biol. 2013 Jan 8;3(1):120139.
   PubMed Web of Science ®Google Scholar
• Khan AM, Miotto O, Heiny AT, et al. A systematic bioinformatics approach for selection of epitope-based vaccine targets. Cell Immunol. 2006 Dec;244(2):141–147
   PubMed Web of Science ®Google Scholar
• Hajissa K, Zakaria R, Suppian R, et al. Epitope-based vaccine as a universal vaccination strategy against Toxoplasma gondii infection: a mini-review. J Adv Vet Anim Res. 2019 Jun;6(2):174–182.
   PubMed Web of Science ®Google Scholar
• Song PX, Yao SH, Yao Y, et al. Epitope analysis and efficacy evaluation of phosphatase 2C (PP2C) DNA Vaccine Against Toxoplasma gondii infection. J Parasitol. 2020 Aug 1;106(4):513–521.
   PubMed Web of Science ®Google Scholar
• Cong H, Yuan Q, Zhao Q, et al. Comparative efficacy of a multi-epitope DNA vaccine via intranasal, peroral, and intramuscular delivery against lethal Toxoplasma gondii infection in mice. Parasit Vectors. 2014 Mar 31;7(1):145.
   PubMedGoogle Scholar
• Greenland JR, Letvin NL. Chemical adjuvants for plasmid DNA vaccines. Vaccine. 2007 May 10;25(19):3731–3741.
   PubMed Web of Science ®Google Scholar
• Montomoli E, Piccirella S, Khadang B, et al. Current adjuvants and new perspectives in vaccine formulation. Expert Rev Vaccines. 2011 Jul;10(7):1053–1061
   PubMed Web of Science ®Google Scholar
• Li L, Petrovsky N. Molecular mechanisms for enhanced DNA vaccine immunogenicity. Expert Rev Vaccines. 2016;15(3):313–329.
   PubMed Web of Science ®Google Scholar
• Ahmadpour E, Sarvi S, Hashemi Soteh MB, et al. Evaluation of the immune response in BALB/c mice induced by a novel DNA vaccine expressing GRA14 against Toxoplasma gondii. Parasite Immunol. 2017 Apr;39(4):e12419
   Web of Science ®Google Scholar
• Ghaffarifar F, Jafarimodrek M, Vazini H, et al. Assessment of DNA vaccine encoding Toxoplasma gondii microneme complete gene and IL-12 as adjuvant in BALB/c mice. Iran J Basic Med Sci. 2019 Aug;22(8):901–907
   PubMed Web of Science ®Google Scholar
• Sun H, Li J, Xiao T, et al. Protective immunity induced by a DNA vaccine cocktail expressing TgSAG1, TgROP2, and the genetic adjuvant HBsAg against Toxoplasma gondii infection. Microb Pathog. 2020 Oct;147:104441.
   PubMed Web of Science ®Google Scholar
• Roozbehani M, Falak R, Mohammadi M, et al. Characterization of a multi-epitope peptide with selective MHC-binding capabilities encapsulated in PLGA nanoparticles as a novel vaccine candidate against Toxoplasma gondii infection. Vaccine. 2018 Oct 1;36(41):6124–6132.
   PubMed Web of Science ®Google Scholar
• Bureau MF, Naimi S, Torero Ibad R, et al. Intramuscular plasmid DNA electrotransfer: biodistribution and degradation. Biochim Biophys Acta. 2004 Jan 20;1676(2):138–148.
   PubMedGoogle Scholar
• Yoshida A, Nagata T, Uchijima M, et al. Advantage of gene gun-mediated over intramuscular inoculation of plasmid DNA vaccine in reproducible induction of specific immune responses. Vaccine. 2000 Mar 6;18(17):1725–1729.
   PubMed Web of Science ®Google Scholar
• Garcia JL. Vaccination concepts against Toxoplasma gondii. Expert Rev Vaccines. 2009 Feb;8(2):215–225.
   PubMed Web of Science ®Google Scholar
• Pifer R, Yarovinsky F. Innate responses to Toxoplasma gondii in mice and humans. Trends Parasitol. 2011 Sep;27(9):388–393.
   PubMed Web of Science ®Google Scholar
• Dziadek B, Gatkowska J, Brzostek A, et al. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis. Vaccine. 2011 Jan 17;29(4):821–830.
   PubMed Web of Science ®Google Scholar
• Dziadek B, Gatkowska J, Grzybowski M, et al. Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice. Exp Parasitol. 2012 May;131(1):133–138
   PubMed Web of Science ®Google Scholar
• Brown CR, Hunter CA, Estes RG, et al. Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. Immunology. 1995 Jul;85(3):419–428.
   PubMed Web of Science ®Google Scholar
• Vercammen M, Scorza T, Huygen K, et al. DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice. Infect Immun. 2000 Jan;68(1):38–45
   PubMed Web of Science ®Google Scholar
• Echeverria PC, de Miguel N, Costas M, et al. Potent antigen-specific immunity to Toxoplasma gondii in adjuvant-free vaccination system using Rop2-Leishmania infantum Hsp83 fusion protein. Vaccine. 2006 May 8;24(19):4102–4110.
   PubMed Web of Science ®Google Scholar
• Song X, Xu L, Yan R, et al. The optimal immunization procedure of DNA vaccine pcDNA–TA4–IL-2 of Eimeria tenella and its cross-immunity to Eimeria necatrix and Eimeria acervulina. Vet Parasitol. 2009;159(1):30–36.
   PubMed Web of Science ®Google Scholar
• Warner RC, Chapman RC, Davis BN, et al. REVIEW OF DNA VACCINE APPROACHES AGAINST THE PARASITE TOXOPLASMA GONDII. J Parasitol. 2021 Nov 1;107(6):882–903.
   PubMed Web of Science ®Google Scholar
• Javadi Mamaghani A, Fathollahi A, Spotin A, et al. Candidate antigenic epitopes for vaccination and diagnosis strategies of Toxoplasma gondii infection: a review. Microb Pathog. 2019 Dec;137:103788.
   PubMed Web of Science ®Google Scholar
• Mamaghani AJ, Fathollahi A, Arab-Mazar Z, et al. Toxoplasma gondii vaccine candidates: a concise review. Ir J Med Sci. 2022 Apr;8:1–31.
   Google Scholar
• Buxton D, Innes EA. A commercial vaccine for ovine toxoplasmosis. Parasitology. 1995;110(Suppl):S11–6.
   PubMedGoogle Scholar
• Jongert E, Roberts CW, Gargano N, et al. Vaccines against Toxoplasma gondii: challenges and opportunities. Mem Inst Oswaldo Cruz. 2009 Mar;104(2):252–266
   PubMed Web of Science ®Google Scholar
• Babiuk LA, Pontarollo R, Babiuk S, et al. Induction of immune responses by DNA vaccines in large animals. Vaccine. 2003 Jan 30;21(7–8):649–658.
   PubMed Web of Science ®Google Scholar
• Behnke MS, Khan A, Wootton JC, et al. Virulence differences in Toxoplasma mediated by amplification of a family of polymorphic pseudokinases. Proc Natl Acad Sci U S A. 2011 Jun 7;108(23):9631–9636.
   PubMed Web of Science ®Google Scholar
• Choi J, Biering SB, Hwang SQV. Interferon-inducible GTPases go to their target membranes via the LC3-conjugation system of autophagy. Small GTPases. 2017 Oct 2;8(4):199–207.
   PubMedGoogle Scholar